(CLB)

Reporting relationship: CAO & Treasurer
Issuer ticker: CLB
Reported as of: 15 Feb 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Feb 2024, 16:11:18 UTC
Prior SEC filing: 03 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Kevin Daniels filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 15 Feb 2024.

Key facts

This page summarizes Kevin Daniels's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Feb 2024, 16:11.

Change

Previous filing in this sequence was filed on 03 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLB transaction Derivative

Performance Shares

Award

Transaction value: $0
Shares: +8,882
Change %
Price: $0.000000
Shares after: 8,882
Date: 15 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,882
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the"Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 200% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 100% up to 200% of the award).